Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cufflinks statistical model

    I needed a little help in understanding the abundance estimation by
    Cufflinks.
    Please refer to cufflinks supplementary methods.

    Let me reiterate some of the key points/definitions; for the sake of
    convenience of explanation.

    ρ(t) = abundance of transcript t
    α(t) = probability of choosing a transcript t
    [identified by abundance and length]
    β(g) = sum(α(t)) (t belongs to g) = probability of choosing a transcript from
    a locus g
    γ(t) = probability that chosen transcript has given abundance and length

    Question 1: Does that mean that a transcript is fully identified by its
    length and abundance ?

    Question 2: In the parameter estimation section, I didnt quite understand
    how MLE of β becomes X(g)/M.
    Shouldnt it be the solution of ∑ ∂(X(g).log(β(g)))/∂β(g) = 0 ?

    Question 3: I dont understand importance sampling method much, but is
    there an intuitive way of understanding how is γ estimated from input
    variable i.e. reads ?

    FPKM calculation has l(t) in denominator. Cufflinks should accept any
    SAM/BAM file regardless of whether its passed through Tophat. If I pass to
    cufflinks, the reads aligned to transcriptome (refseq), and I dont provide
    any annotations, then:

    Question 4: How is a locus designated ?
    Question 5: How is l(t) estimated for FPKM calculation; length of a
    transcript should be smaller than a locus?


    Finally, how can I use cufflinks without involving genome alignments !?

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 06:25 AM
0 responses
13 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 01:02 PM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-18-2024, 06:39 AM
0 responses
14 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
14 views
0 likes
Last Post seqadmin  
Working...
X